Member Info for Newuncle

For those sellers, hope you sold ALL your shares and never return.

It never ceases to amaze me how fickle people can be, MMs must love these types who fill their nappies every time they see any of their shares go red and panic themselves out, easy pickings for MMs and they know it which is exactly why they act the way they do.

So true and apt:

7rademark20 Jun '24 - 10:03 - 3646 of 3648

It's the sellers who don't check the limits that astound me. We can have a block of buys the mms go NT to buy and wait for the mug seller. Who is then followed by more sellers.

CPX - From Myles M

Some consolidation in trading yesterday and this morning, after the meteoric rise on Tuesday - but I get the feeling that the rerate is only really just getting underway. I suspect that New NED and largest shareholder (~12%), Dr Cooley (of ITM Power fame) has big plans for the company.

Take you fast profits here and BUY CPX

OK, thanks.

So now it's all down to timing and volume of sales going forwards.

Gimme,

Also re challenging circumstances quote, yes it relates to market conditions but, and this is important, the FD etc left it until the very last minute to raise funds after the share price had fallen considerably over months after their previous results despite many of us here saying they should have done it far sooner so again I question the BoD judgement in their very poor choice of timing in raising funds when they did, yes it would still have been difficult/challenging but at least it could have been from a much higher price had they acted sooner and not sat on their hands.

Trax, I think you just answered your own question there. MMs/Brokers doing their thing short term for a buyer sounds about right to me

Blindingly obvious....not very nice term to use but lets leave it that.

Back to reality here without the personal jibes, OBD needs to increase test numbers, significantly and quickly to achieve a run rate of 1,000 a month, especially as stated by the FD "operating costs, which have increased relative to prior periods".

Yes I would like to think at least one TR1 is due here any day

Well fwiw I am guessing "challenging markets/conditions" actually relates to ability to raise funds via equity issues etc which was clearly reflected in the discounted share price value needed to get the cash despite the FD saying previously he was confident in raising funds as they had always done so at premiums in the past.

As for the current case for buying, I will be watching and waiting, why? Simply put the company has a fairly high bar of test numbers it needs to deliver to address the following:

Cash resources as predicted in the forecast are very sensitive to changes in the assumptions related to these uncertainties: this was noted in an alternative 'low growth scenario' considered by the Directors that reflects reduced test volumes compared to the forecast and assumes no new projects for pharma customers. Without any remedial action to reduce costs or delay expenditure, in this scenario the Group and Company would need to obtain additional funds during the first quarter of 2025 in order to continue as a going concern.

Revenue during the period ended 31 March 2024 was increased slightly compared to each of the preceding two half-year periods, but the Group remained lossmaking with income significantly exceeded by operating costs, which have increased relative to prior periods. The Group was able to maintain its cash reserves during and after the period, including through the raising of £9.86m (before costs) through a placing, subscription and PrimaryBid offer announced in March 2024 and approved by shareholders after the period end in April 2024. During the year ended 30 September 2023, the Group raised a total of £15.4m (before costs) from new and existing shareholders, in two fundraises. However, as at the date of publication of this report, there is no guarantee that the Group will be able to access further cash resources from investors. This issue may be compounded if the Company's share price were to fall further from its current level.

The Directors do not believe that any of the factors above is unusual or unexpected for the Group at this point in the execution of its strategy. However, shareholders should be aware that there is uncertainty around its ability to generate sufficient revenues and the timing of receipts from customers, as well as the ability of the Group to raise sufficient finance to meet its expected costs. These conditions present a material uncertainty which may cast significant doubt on the Group and Parent Company's ability to continue as a going concern and, therefore, it may be unable to realize its assets and discharge its liabilities in the normal course of business.

BLUE opening!

Is my monitor broken?

An awful lot of buys showing?

True, not worth the effort

Btw they are points anyone can comment on.

Chill out, they are perfectly legitimate points I am raising and yes it's guesswork to judge but this is a discussion board after all and Kong has been seriously flamed for his views which imo is wrong but seems acceptable to you .

And what are challenging markets for their tests please?

Ok so on what basis could obd at least break even.. how many tests a day are needed every day. Is it 10, 20, 30.... Etc

Or was it out of pure jealousy?

Kat just say honestly why you felt the need to post negatives on a share you have never posted on previously and we can move on ... Up to you

Aren't they selling all their assets to bet the farm on a becoming a potential helium player? Pretty sure their finances are fooked and they were losing £millions in oil. Assets sales money is still some way off too is it not? I think quite a few got burned on the last big helium play recently?